CAS: 182163-96-8; 3,4,5-Trimethoxyphenylboronic Acid

该化合物是一种有机有机体化合物,其特点是,在苯环上有一个附于苯环的碱酸功能组,在3,4和5个位置上又用三种甲氧基组替代.该化合物一般是白色的,在白色的固体中是白色的,在极地有机溶剂中是可溶的.由于存在溴酸组,它成为有机合成中的一种有价值的试剂,特别是在铃木混合反应中,广泛用于形成碳-碳结.甲基氧子体提高了芳香环的电子密度,影响其再活性和稳定性.此外,该化合物还可能具有有趣的特性,例如由于它能够形成与各种子质的复合体,有可能在药用化学和材料科学中应用.其分子结构允许多用途的改变,使它成为合成更复杂的有机分子的有益构件.在处理和储存时,应参考安全数据,因为所有化学物质都是如此.

结构式图片

欧盟法规

C&L通报

上下游产品

CAS号2675-79-8 5-溴-1,2,3-三甲氧基苯 | CAS号121-43-7 硼酸三甲酯 | CAS号133095-91-7 3,4,5-三甲氧基苯基溴化镁 | CAS号25245-29-8 5-碘-1,2,3-三甲氧基苯 | CAS号24313-88-0 3,4,5-三甲氧基苯胺 | CAS号1016971-56-4 2,4,6-tris(3,4,... | CAS号1016971-65-5 2,4-bis(4-metho... | CAS号1016971-69-9 2,4-bis(3,5-di-... | CAS号487-11-6 5-烯丙基-1,2,3-三甲氧基苯 | CAS号1885-35-4 3,4,5-三甲氧基苯甲腈 | CAS号1016971-56-4 2,4,6-tris(3,4,... | CAS号34907-38-5 2,4,6-TRIS(3,5-... | CAS号1528-74-1 4,4-二硝基联苯 | CAS号1146731-51-2 N-B°C-2-(4-nitr... | CAS号56772-00-0 3,3',4,4',5,5'-... | CAS号65684-98-2 2-phenyl-5-(3,4...

合成工艺路线路线简述

    1-溴-3,4,5-三甲氧基苯置于正丁基锂,硼酸三甲酯体系中,用 四氢呋喃,正己烷 用作溶剂,化学反应 19.0H,以64%的收率获得3,4,5-三甲氧基苯硼酸
    参考文献:四苯乙烯衍生柱状液晶及其氧化光环化
    标题:四苯乙烯衍生柱状液晶及其氧化光环化
    摘要:描述了通过 Mcmurry 反应和 Suzuki 偶联作为关键步骤合成带有醚,联苯和 4-氰基联苯部分的新型四苯基乙烯 9A-F,13 和 18A,B.通过差示扫描量热法 (Dsc),光学偏光显微镜和 X 射线衍射研究了这些化合物的介晶性质.链长为 C8 或 C9 的醚取代衍生物 9A,B 是非介晶的.具有较长烷基链的化合物 9C-F 显示六方柱状中间相.虽然氰基联苯衍生物 13 是非介晶的,但相应的联苯系统 18A,B 分别具有癸氧基和十二烷氧基链,形成六方柱状中间相.研究了化合物 1F,9C,13 和 18A 的氧化光环化.在碘四苯乙烯 1F 存在下照射后,9C得到相应的菲22A,B.22A,B 的介晶性质强烈依赖于取代基.而醚 22A 仅显示各向同性熔化,而发现酯 22B 为六方柱状中间相.(© Wiley-Vch Verlag Gmbh & Co. Kgaa,69451 Weinheim
    Doi:10.1002/ejoc.200300118

    海关参考信息

    专利信息


    专利号:US-9573873-B2
    优先权日:2014-06-03
    标题:Catalytic method for dibenzocycloheptane synthesis and allocolchicinoid synthesis
    发明人:GREEN JAMES; MEHDI MARIAM; DJURDJEVIC SINISA
    权利人:UNIV OF WINDSOR
    摘要:In a non-limiting embodiment, there is provided a compound of formula (I), which may permit for a method or use in treating or preventing a cancer, such as pancreatic cancer or leukemia. In one embodiment, there is also provide a method of preparing a compound of formula (Ia), the method including conducting a cyclization reaction of a compound of formula (III) to obtain a compound of formula (IV), wherein conducting the cyclization reaction comprises conducting a Michael reaction in the presence of a Lewis acid.

    专利号:WO-2004087679-A1
    优先权日:2003-04-01
    标 题 :2, 4, 6-trisubstituted pyrimidine derivatives useful for the treatment of neoplastic and autoimmune diseases
    发明人:OBRECHT DANIEL; ERMERT PHILIPP; LUTHER ANATOL; EBERLE MARTIN; BACHMANN FELIX
    权利人:APONETICS AG; OBRECHT DANIEL; ERMERT PHILIPP; LUTHER ANATOL; EBERLE MARTIN; BACHMANN FELIX
    摘要:The invention relates to substituted pyrimidines of formula (I) wherein V represents a bond or CR6R7, W represents a bond, NR8 or oxygen, X represents sulfur, or nitrogen substituted by hydrogen or R5, Y represents -CH2-, -CH2CH2-, -CO- or -CS-, R1 represents unsubstituted or substituted aryl or heteroaryl, and the substituents R2, R3, R4, R5, R6, R7 and R8 have the meanings given in the specification. These compounds are selectively inducing apoptosis in cancer cells and can be used for the treatment of neoplastic and autoimmune diseases. The invention relates also to methods of synthesis of such compounds, to their use as medicaments, to pharmaceutical compositions containing same, and to methods of treatment of neoplastic and autoimmune diseases using such compounds of formula (I) or of pharmaceutical compositions containing same.

    专利号:US-9611281-B2
    优先权日:2013-12-05
    标题:BODIPY derivatives and methods of synthesis and use thereof
    发明人:YOU YOUNGJAE; AWUAH SAMUEL; WATLEY RYAN
    权利人:UNIV OKLAHOMA
    摘要:Derivatives of BODIPY (boron dipyrromethene difluoride) and their synthesis and use are disclosed.

    专利号:US-7572778-B2
    优先权日:2003-07-18
    标题 :Fluorocombretastatin and derivatives thereof
    发明人:GIANNINI GIUSEPPE; ALLOATTI DOMENICO; MARCELLINI MARCELLA; MARZI MAURO; RICCIONI TERESA; TINTI MARIA ORNELLA
    权利人:SIGMA TAU IND FARMACEUTI
    摘要:The present invention is related to new derivatives of Combretastatin, of Formula n nobtained by total synthesis. The strategy developed for each of the compounds is to i) replace a halogen (i.e. fluorine atom) to hydrogen on olefinic bound; ii) replace an aromatic ring in a natural product with an amino-aromatic ring. Said compounds recognize and bind the tubulin site: are useful for treating pathological states which arise from or are exacerbated by cell proliferation—as anticancer and/or antiangiogenic activity, in a mammal—to pharmaceutical compositions comprising these compounds.

    专利号:US-11306103-B2
    优先权日:2017-11-30
    标题:Thieno[3,2-b]pyridine-5(4H)-one derivative compound, preparation method thereof and use thereof
    发明人:LEE JONG SEOK; SUNG DAN BI; MUN BO HYUN; LEE HYI SEUNG; LEE YEON JU; LEE JI HOON; SHIN HEE JAE; PARK SOL
    权利人:KOREA INST OCEAN SCI & TECH
    摘要:The present invention relates to a novel thieno[3,2-b]pyridine-5(4H)-one derivative compound, a preparation method thereof, and a use thereof. The novel thieno[3,2-b]pyridine-5(4H)-one derivative compound according to the present invention is synthesized via an aza-[3+3] cyclization addition reaction using BOP, wherein the compound is obtained by synthesizing a 4-arylthiophen-3-amine in which aryl groups such as 4-piperidyl-C6H4, 4-pyrrolidyl-C6H4, 4-MeOC6H4, 3,4,5-(MeO)3C6H4, C6H5, 4-C6H5C6H4, and 4-F3COC6H4 are introduced via a synthesis process by a bromination reaction, a hydrolysis reaction, a decarboxylation reaction, and a Suzuki coupling reaction of methyl 3-aminothiophene carboxylate, and by synthesizing 4-arylthiophen-3-amine and mono-methyl fumarate via a formal aza-[3+3] cyclization addition reaction using BOP and conjugation. Accordingly, novel thieno[3,2-b]pyridine-5(4H)-one derivative compounds according to the present invention have fluorescence properties with a wide range of emission wavelengths and thus may be utilized in various industrial fields such as physics, chemistry, and biomedical research.

    专利号:US-2015158888-A1
    优先权日:2013-12-05
    标题:BODIPY Derivatives and Methods of Synthesis and Use Thereof
    珠海奥博凯生物医药技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.aobchem.com.cn
    企业联系电话:15697568807👤
    📞珠海奥博凯生物医药技术有限公司 ⚠️参考联系方式
    联系人:赵金杰
    电话:15697568807
    手机:15697568807

    邮箱:zhao.jinjie@aobchem.com.cn
    通信地址: 广东省珠海市金湾区红旗镇珠海大道6698号美满车城1号楼东侧3楼
    邮编: 519090
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:广东省珠海市金湾区红旗镇珠海大道6698号美满车城1号楼东侧3楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    北京普瑞东方化学技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bjpurechem.com
    企业联系电话:010-83993285👤
    📞北京普瑞东方化学技术有限公司 ⚠️参考联系方式
    联系人:冷先生
    电话:010-83993285
    手机:17610176018
    传真:010-63370219
    邮箱:sales@bjpurechem.com
    通信地址: 北京市海淀区西三环北路50号院6号楼豪柏大厦1708室
    邮编: 100048
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:北京市海淀区西三环北路50号院6号楼豪柏大厦1708室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Tomé, A. C., Science of Synthesis Knowledge Updates, (2015) 2, 89.
    摘要:Guram, A. S.; Milne, J. E.; Tedrow, J. S.; Walker, S. D., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 1, 22.
    摘要:Guram, A. S.; Milne, J. E.; Tedrow, J. S.; Walker, S. D., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 1, 102.
    摘要:Le Bras, J.; Muzart, J., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 3, 187.
    摘要:Cormier, M.; Goddard, J.-P., Science of Synthesis, (2020) , 171.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知